Firmonertinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Firmonertinib, covering 2024-12-12 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations [Phase 3]